Team-based learning course
The International Society on Thrombosis and Haemostasis (ISTH) has launched a new team-based learning course focused on bringing together early-career physicians from around the world to collaborate on complex cases in bleeding and clotting.
The course features three case modules on these topics:
- Cancer-associated thrombosis
- Congenital hemophilia with inhibitors
- Treatment duration in patient with recurrent thrombosis and high bleeding risk.
The course will accommodate three learning teams, each consisting of up to seven students (15-21 total students) and two facilitators (six total facilitators), who will mentor the students. The virtual course lasts 14 weeks, March 25-June 28, with a final in-person meeting in Montréal, Canada, at the ISTH 2023 Congress (virtual attendance also available). Learning teams will meet virtually at least once weekly, with a gap week between each module.
Students will be assigned three complex cases based on real patients. Over the next 14 weeks, they will work virtually with their peers and expert facilitators to diagnose and develop treatment plans. The final meeting will take place at the ISTH 2023 Congress in Montreal.
Students will be awarded a certificate upon successful completion of the course with 75% attendance.
Course learning objectives:
By the end of the course, the participants will be able to:
- Manage parenteral and oral anticoagulation treatment of cancer-associated thrombosis in settings of malignancies with high bleeding risk
- Design a treatment plan, including immunotolerance, in patients with congenital hemophilia with inhibitors
- Make evidence-based decisions on treatment type and duration in patients with recurrent thrombosis and concomitant high risk for bleeding.
Students should be early-career physicians with at least three years of experience in a center managing bleeding and/or thrombotic disorders.
#ISTHEarlyCareer